Use of Endosulfan be allowed for next 2 yrs: Committee to SC

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 6:29 AM IST

"The Ministry of Agriculture informed that in India, if no further import of raw material is allowed, the existing stock should be depleted within a period of two years after its manufacture.

"Taking into consideration all these facts, the Committee felt that that to exhaust the available stocks of the raw material, manufacture and use of Endosulfan may be permitted for a total period of two years," the report, filed before a bench of justices Swatanter Kumar and Madan B Lokur, said.

The recommendations of the expert committee, headed by Indian Council of Medical Research scientist R S Dhaliwal, would now be considered by the court on November 29.

The panel, in its report, said, "The manufacturing and marketing companies should be asked to ensure to completely exhaust the available raw material during this period and ensure that that this pesticide is fully utilised in accordance with label claim and good agricultural practices for pest control."

The court-appointed committee observed that Endosulfan has "important health hazards/biological effects related to endocrine disruption, carcinogenicity, congenital anomalies and reproductive and neurological abnormalities."

The report also said that other pesticides "by nature, are toxic compound" having certain "unwanted effects".

The court is hearing a petition filed by Democratic Youth Federation of India that sought a ban on Endosulfan on the ground that it was causing health hazards including genetic disorders. (More)

  

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 20 2012 | 8:25 PM IST

Next Story